BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18459158)

  • 1. HLA-class I expression in gastric cancer.
    Ishigami S; Natsugoe S; Nakajo A; Arigami T; Kitazono M; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Aikou T
    J Surg Oncol; 2008 Jun; 97(7):605-8. PubMed ID: 18459158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.
    Ye Q; Shen Y; Wang X; Yang J; Miao F; Shen C; Zhang J
    Tissue Antigens; 2010 Jan; 75(1):30-9. PubMed ID: 19883394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
    Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
    J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of HLA class I expression in prostate cancer: implications for immunotherapy.
    Blades RA; Keating PJ; McWilliam LJ; George NJ; Stern PL
    Urology; 1995 Nov; 46(5):681-6; discussion 686-7. PubMed ID: 7495121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
    Rolland P; Deen S; Scott I; Durrant L; Spendlove I
    Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of MHC class II-associated invariant chain expression in human gastric carcinoma.
    Tamori Y; Tan X; Nakagawa K; Takai E; Akagi J; Kageshita T; Egami H; Ogawa M
    Oncol Rep; 2005 Oct; 14(4):873-7. PubMed ID: 16142345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
    Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
    Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
    Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
    Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
    Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
    Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer.
    Osaki T; Saito H; Yoshikawa T; Matsumoto S; Tatebe S; Tsujitani S; Ikeguchi M
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):382-7. PubMed ID: 17255258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G expression in gastric cancer.
    Ishigami S; Natsugoe S; Miyazono F; Nakajo A; Tokuda K; Matsumoto M; Okumura H; Douchi T; Hokita S; Aikou T
    Anticancer Res; 2006; 26(3B):2467-72. PubMed ID: 16821634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
    Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
    J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
    Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the expression of major histocompatibility complex class I genes in human colorectal cancer.
    Soong TW; Hui KM
    Cancer Detect Prev; 1991; 15(3):231-9. PubMed ID: 1905582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MHC class I expression and lymph node metastasis of gastric carcinoma.
    Yoshii M; Tanaka H; Ohira M; Muguruma K; Sakurai K; Kubo N; Yashiro M; Sawada T; Hirakawa K
    Hepatogastroenterology; 2013 May; 60(123):611-5. PubMed ID: 23108078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
    Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.